164 related articles for article (PubMed ID: 37969188)
1. Gene expression profiles to analyze the anticancer and carcinogenic effects of arsenic in bladder cancer.
Han X; Zhang T; Ma Q; Chang R; Xin S; Yu Q; Zhang G; Wang Y
Am J Transl Res; 2023; 15(10):5984-5996. PubMed ID: 37969188
[TBL] [Abstract][Full Text] [Related]
2. Association between Arsenic Level, Gene Expression in Asian Population, and In Vitro Carcinogenic Bladder Tumor.
Singhal S; Ruprecht NA; Sens D; Tavakolian K; Gardner KL; Singhal SK
Oxid Med Cell Longev; 2022; 2022():3459855. PubMed ID: 35039759
[TBL] [Abstract][Full Text] [Related]
3. Identifying arsenic trioxide (ATO) functions in leukemia cells by using time series gene expression profiles.
Yang H; Lin S; Cui J
Gene; 2014 Feb; 535(2):312-7. PubMed ID: 24262935
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.
Zhang XW; Yan XJ; Zhou ZR; Yang FF; Wu ZY; Sun HB; Liang WX; Song AX; Lallemand-Breitenbach V; Jeanne M; Zhang QY; Yang HY; Huang QH; Zhou GB; Tong JH; Zhang Y; Wu JH; Hu HY; de Thé H; Chen SJ; Chen Z
Science; 2010 Apr; 328(5975):240-3. PubMed ID: 20378816
[TBL] [Abstract][Full Text] [Related]
5. Metabolism and the paradoxical effects of arsenic: carcinogenesis and anticancer.
Cui X; Kobayashi Y; Akashi M; Okayasu R
Curr Med Chem; 2008; 15(22):2293-304. PubMed ID: 18781951
[TBL] [Abstract][Full Text] [Related]
6. Balance between the toxicity and anticancer activity of arsenic trioxide in treatment of acute promyelocytic leukemia.
Wang QQ; Hua HY; Naranmandura H; Zhu HH
Toxicol Appl Pharmacol; 2020 Dec; 409():115299. PubMed ID: 33091440
[TBL] [Abstract][Full Text] [Related]
7. Double-edged effects of arsenic compounds: anticancer and carcinogenic effects.
Rehman K; Naranmandura H
Curr Drug Metab; 2013 Dec; 14(10):1029-41. PubMed ID: 24164099
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis and identification of key genes and signaling pathways in the occurrence and metastasis of cutaneous melanoma.
Dai H; Guo L; Lin M; Cheng Z; Li J; Tang J; Huan X; Huang Y; Xu K
PeerJ; 2020; 8():e10265. PubMed ID: 33240619
[TBL] [Abstract][Full Text] [Related]
9. The genomic landscape of sensitivity to arsenic trioxide uncovered by genome-wide CRISPR-Cas9 screening.
Chen JZ; Wang LN; Luo XQ; Tang YL
Front Oncol; 2023; 13():1178686. PubMed ID: 37251921
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic effects of arsenic trioxide on acute promyelocytic leukemia and other types of leukemias.
Yousefnia S
Cell Biol Int; 2021 Jun; 45(6):1148-1157. PubMed ID: 33527587
[TBL] [Abstract][Full Text] [Related]
11. Biotransformation of arsenic trioxide by AS3MT favors eradication of acute promyelocytic leukemia: revealing the hidden facts.
Maimaitiyiming Y; Zhu HH; Yang C; Naranmandura H
Drug Metab Rev; 2020 Aug; 52(3):425-437. PubMed ID: 32677488
[TBL] [Abstract][Full Text] [Related]
12. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
13. Metabolism, toxicity and anticancer activities of arsenic compounds.
Khairul I; Wang QQ; Jiang YH; Wang C; Naranmandura H
Oncotarget; 2017 Apr; 8(14):23905-23926. PubMed ID: 28108741
[TBL] [Abstract][Full Text] [Related]
14. Arsenic induced epigenetic changes and relevance to treatment of acute promyelocytic leukemia and beyond.
Maimaitiyiming Y; Wang QQ; Hsu CH; Naranmandura H
Toxicol Appl Pharmacol; 2020 Nov; 406():115212. PubMed ID: 32882258
[TBL] [Abstract][Full Text] [Related]
15. PML-RARα interaction with TRIB3 impedes PPARγ/RXR function and triggers dyslipidemia in acute promyelocytic leukemia.
Li K; Wang F; Yang ZN; Cui B; Li PP; Li ZY; Hu ZW; Zhu HH
Theranostics; 2020; 10(22):10326-10340. PubMed ID: 32929351
[TBL] [Abstract][Full Text] [Related]
16. Activation of PPARγ intensified the effects of arsenic trioxide in acute promyelocytic leukemia through the suppression of PI3K/Akt pathway: Proposing a novel anticancer effect for pioglitazone.
Esmaeili S; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Salari S; Gharehbaghian A; Hamidpour M; Bashash D
Int J Biochem Cell Biol; 2020 May; 122():105739. PubMed ID: 32169580
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of hub genes and molecular mechanisms in non-alcoholic steatohepatitis based on the gene expression omnibus database].
Li LY; Wu JX
Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(40):3317-3322. PubMed ID: 34758532
[No Abstract] [Full Text] [Related]
18. PI3K/Akt/mTOR Signaling Pathway and the Biphasic Effect of Arsenic in Carcinogenesis.
Chen QY; Costa M
Mol Pharmacol; 2018 Jul; 94(1):784-792. PubMed ID: 29769245
[TBL] [Abstract][Full Text] [Related]
19. Role of PML SUMOylation in arsenic trioxide-induced fibrosis in HSCs.
Dai J; Hu Y; Niu Q; Song G; Wang H; Li S
Life Sci; 2020 Jun; 251():117607. PubMed ID: 32240679
[TBL] [Abstract][Full Text] [Related]
20. Eleven genes associated with progression and prognosis of endometrial cancer (EC) identified by comprehensive bioinformatics analysis.
Liu J; Zhou S; Li S; Jiang Y; Wan Y; Ma X; Cheng W
Cancer Cell Int; 2019; 19():136. PubMed ID: 31139013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
